6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine

C102H85F8N29OS — CID 159999874

IUPAC6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine
SMILESCc1cc(C)c2nc(C)n(-c3cncc(Nc4ccc(C(F)(F)F)cc4)n3)c2c1.Cc1nc2cc(F)c(F)cc2n1-c1cncc(Nc2ccc(N3CCOCC3)nc2)n1.Cc1nc2ccccc2n1-c1cncc(NC2Cc3ccccc3C2)n1.Cc1nc2ccccc2n1-c1cncc(Nc2nc3ccccc3s2)n1.FC(F)(F)c1ccc(Nc2cncc(-c3c(C4CC4)nc4ncccn34)n2)cc1
InChIInChI=1S/C21H18F3N5.C21H19F2N7O.C21H19N5.C20H15F3N6.C19H14N6S/c1-12-8-13(2)20-17(9-12)29(14(3)26-20)19-11-25-10-18(28-19)27-16-6-4-15(5-7-16)21(22,23)24;1-13-26-17-8-15(22)16(23)9-18(17)30(13)21-12-24-11-19(28-21)27-14-2-3-20(25-10-14)29-4-6-31-7-5-29;1-14-23-18-8-4-5-9-19(18)26(14)21-13-22-12-20(25-21)24-17-10-15-6-2-3-7-16(15)11-17;21-20(22,23)13-4-6-14(7-5-13)26-16-11-24-10-15(27-16)18-17(12-2-3-12)28-19-25-8-1-9-29(18)19;1-12-21-13-6-2-4-8-15(13)25(12)18-11-20-10-17(23-18)24-19-22-14-7-3-5-9-16(14)26-19/h4-11H,1-3H3,(H,27,28);2-3,8-12H,4-7H2,1H3,(H,27,28);2-9,12-13,17H,10-11H2,1H3,(H,24,25);1,4-12H,2-3H2,(H,26,27);2-11H,1H3,(H,22,23,24)
InChIKeyOIAJAKVAVIBCJI-UHFFFAOYSA-N
MW1917.05 g/mol
LogP21.89
Rot. Bonds17

About 6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine

6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine (PubChem CID 159999874) has the molecular formula C102H85F8N29OS and a molecular weight of 1917.05 g/mol. Its IUPAC name is 6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine.

Molecular Properties

Compound Name6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine
PubChem CID159999874
Molecular FormulaC102H85F8N29OS
Molecular Weight1917.05 g/mol
Exact Mass1915.71
IUPAC Name6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine
SMILESCc1cc(C)c2nc(C)n(-c3cncc(Nc4ccc(C(F)(F)F)cc4)n3)c2c1.Cc1nc2cc(F)c(F)cc2n1-c1cncc(Nc2ccc(N3CCOCC3)nc2)n1.Cc1nc2ccccc2n1-c1cncc(NC2Cc3ccccc3C2)n1.Cc1nc2ccccc2n1-c1cncc(Nc2nc3ccccc3s2)n1.FC(F)(F)c1ccc(Nc2cncc(-c3c(C4CC4)nc4ncccn34)n2)cc1
InChIInChI=1S/C21H18F3N5.C21H19F2N7O.C21H19N5.C20H15F3N6.C19H14N6S/c1-12-8-13(2)20-17(9-12)29(14(3)26-20)19-11-25-10-18(28-19)27-16-6-4-15(5-7-16)21(22,23)24;1-13-26-17-8-15(22)16(23)9-18(17)30(13)21-12-24-11-19(28-21)27-14-2-3-20(25-10-14)29-4-6-31-7-5-29;1-14-23-18-8-4-5-9-19(18)26(14)21-13-22-12-20(25-21)24-17-10-15-6-2-3-7-16(15)11-17;21-20(22,23)13-4-6-14(7-5-13)26-16-11-24-10-15(27-16)18-17(12-2-3-12)28-19-25-8-1-9-29(18)19;1-12-21-13-6-2-4-8-15(13)25(12)18-11-20-10-17(23-18)24-19-22-14-7-3-5-9-16(14)26-19/h4-11H,1-3H3,(H,27,28);2-3,8-12H,4-7H2,1H3,(H,27,28);2-9,12-13,17H,10-11H2,1H3,(H,24,25);1,4-12H,2-3H2,(H,26,27);2-11H,1H3,(H,22,23,24)
InChIKeyOIAJAKVAVIBCJI-UHFFFAOYSA-N
XLogP21.89
TPSA328.77 Ų
H-Bond Donors5
H-Bond Acceptors31
Rotatable Bonds17
Heavy Atoms141
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001917.05
LogP ≤ 521.89
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1031

Analyze 6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

6-N-(1H-benzimidazol-2-ylmethyl)-2-N-pyrazin-2-yl-9-thiophen-3-ylpurine-2,6-diamine;N-[(6-fluoro-1H-benzimidazol-2-yl)methyl]-2-morpholin-4-yl-9-thiophen-3-ylpurin-6-amine;2-morpholin-4-yl-9-thiophen-3-yl-N-[[4-(trifluoromethyl)-1H-benzimidazol-2-yl]methyl]purin-6-amine;2-morpholin-4-yl-9-thiophen-3-yl-N-[[6-(trifluoromethyl)-1H-benzimidazol-2-yl]methyl]purin-6-amine
CID 157406004
CID 159079625
CID 159079625
(4R)-4-[(1S)-1-fluoroethyl]-3-[2-[[(1S)-1-[4-methyl-7-(trifluoromethyl)-4,5-dihydroimidazo[1,5-a]quinolin-3-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one;(4R)-4-[(1S)-1-fluoroethyl]-3-[2-[[(1S)-1-[5-methyl-7-(trifluoromethyl)-4,5-dihydroimidazo[1,5-a]quinolin-3-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one;(4R)-4-[(1S)-1-fluoroethyl]-3-[2-[[(1S)-1-[6-(trifluoromethyl)imidazo[5,1-b][1,3]benzothiazol-3-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one;(4S)-4-propan-2-yl-3-[2-[[(1S)-1-[8-(trifluoromethyl)-5,6-dihydro-4H-imidazo[1,5-a][1]benzazepin-3-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one
CID 160463047
6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2H-indol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-a]pyrimidine;6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole;6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(2-methyl-3H-indol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;5-[[6-(1-cyclopropylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]-difluoromethyl]-6-fluoro-N-(2-morpholin-4-ylethyl)indazole-2-carboxamide;6-[[6-(1-cyclopropylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-5-fluoro-1,3-benzothiazol-2-amine
CID 161823263
N-tert-butyl-1,3-benzothiazol-2-amine;bis(N-tert-butyl-1,3-dihydroindol-2-imine);N-tert-butyl-1-methylbenzimidazol-2-amine;4-tert-butylmorpholine;3,3-difluoro-1-propan-2-ylazetidine;2-(2,2-dimethylpropyl)naphthalene;2-(2,2-dimethylpropyl)quinoline;3-(2,2-dimethylpropyl)quinoline;N-methyl-N-propan-2-ylcyclopropanamine;1-methyl-N-propan-2-ylindazol-3-amine;2-methyl-N-propan-2-ylpropan-1-amine;2-methyl-N-propan-2-ylpropan-2-amine;2-methylpropylcyclobutane;2-methylpropylcyclohexane;2-methylpropylcyclopentane;6-(2-methylpropyl)isoquinoline;N-propan-2-ylcyclopropanamine;N-propan-2-yl-1H-indazol-3-amine;N-propan-2-ylnaphthalen-1-amine;1-propan-2-ylpiperidine;1-propan-2-ylpyrrolidine
CID 165110879
1-[[3-[[2-[4-[[1-[[2-cyano-1-[[3-[[5-[4-[[1-[[2-cyano-1-[[(2S,4S)-2,4-dimethyl-3-(oxan-4-ylamino)-1-bicyclo[1.1.1]pentanyl]methyl]-4-methylindol-5-yl]methyl]piperidin-4-yl]amino]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-2-yl]pyrazin-2-yl]amino]-1-bicyclo[1.1.1]pentanyl]methyl]-4-methylindol-5-yl]methyl]piperidin-4-yl]amino]-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-2-yl]cyclopropyl]amino]-1-bicyclo[1.1.1]pentanyl]methyl]-4-methyl-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indole-2-carbonitrile
CID 166862874
4-[6-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-3-pyridinyl]morpholine;4-[5-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pyrazin-2-yl]morpholine;4-[6-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-3-pyridinyl]morpholine;4-[7-(7-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)quinolin-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[4,5-c]pyridin-2-yl]morpholine;4-[5-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[1,3]thiazolo[5,4-d]pyrimidin-2-yl]morpholine
CID 157079729
5-(1,3-benzothiazol-6-yl)-6-(4-fluoro-3-methylphenyl)-N-(1-methylpiperidin-4-yl)pyridin-3-amine;6-[2-(4-fluoro-3-methylphenyl)-3-pyridinyl]isoquinoline;4-[3-[6-[2-(3-methylphenyl)-3-pyridinyl]benzimidazol-1-yl]propyl]morpholine;6-[2-(3-methylphenyl)-3-pyridinyl]isoquinoline;6-[2-(3-methylphenyl)-3-pyridinyl]-1-[3-(4-methylpiperazin-1-yl)propyl]benzimidazole
CID 158770403
2,4-dimethyl-5-[8-(2-methylphenyl)imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole;5-[8-(2,4-dimethyl-1,3-thiazol-5-yl)imidazo[1,2-a]pyridin-6-yl]-N-propan-2-yl-1,3-thiazol-2-amine;2-ethoxy-5-[8-(2-methylphenyl)imidazo[1,2-a]pyridin-6-yl]-1,3-thiazole;5-[8-(2-fluorophenyl)imidazo[1,2-a]pyridin-6-yl]-N-(2-morpholin-4-ylethyl)-1,3-thiazol-2-amine;N-propan-2-yl-5-(8-pyridin-4-ylimidazo[1,2-a]pyridin-6-yl)-1,3-thiazol-2-amine
CID 158876974
1-Benzyl-3-methyl-5-propan-2-ylindazole;2-benzyl-3-methyl-5-propan-2-ylindazole;1,3-dimethyl-7-propan-2-ylimidazo[1,5-a]pyridine;6-(1-methylindazol-5-yl)-2-propan-2-ylpyridin-3-amine;4-(1-methylindazol-5-yl)-2-propan-2-yl-1,3-thiazole;1-methyl-5-(1-methyl-4-propan-2-ylimidazol-2-yl)indazole;1-methyl-5-(3-methyl-6-propan-2-yl-2-pyridinyl)indazole;1-methyl-6-propan-2-ylbenzotriazole;1-methyl-5-(6-propan-2-yl-2-pyridinyl)indazole;3-methyl-5-propan-2-yltriazolo[1,5-a]pyridine;3-methyl-7-propan-2-yl-[1,2,4]triazolo[4,3-a]pyridine;1-(oxetan-3-yl)-4-(6-propan-2-yl-2-pyridinyl)piperazine
CID 158966858
4-[6-(7-fluoro-3,15-diazatetracyclo[10.2.1.02,10.04,9]pentadeca-2(10),4(9),5,7-tetraen-15-yl)-3-pyridinyl]morpholine;4-[2-fluoro-4-(7-fluoro-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)phenyl]morpholine;4-[3-fluoro-5-(6-fluoro-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)-2-pyridinyl]morpholine;4-[3-fluoro-5-(7-fluoro-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)-2-pyridinyl]morpholine;4-[5-(6-fluoro-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)-3-pyridinyl]morpholine;4-[6-(6-fluoro-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)-[1,3]thiazolo[4,5-b]pyridin-2-yl]morpholine;4-[6-(6-fluoro-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)-[1,3]thiazolo[4,5-c]pyridin-2-yl]morpholine;4-[5-(9-methyl-3,4-dihydro-1H-pyrido[3,4-b]indol-2-yl)-2-pyridinyl]morpholine;4-[6-(9-methyl-3,4-dihydro-1H-pyrido[3,4-b]indol-2-yl)-3-pyridinyl]morpholine
CID 159184958
N-[4-(3,5-dimethylpyrazol-1-yl)phenyl]-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;2-methyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3-benzothiazol-6-amine;N-[3-(1-methylpyrazol-4-yl)-3aH-pyrrolo[2,3-c]pyridin-7-yl]isoquinolin-5-amine;4-[3-[[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]phenyl]-1,3-thiazol-2-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]isoquinolin-6-amine;3-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylphenyl)imidazo[1,2-a]pyrazin-8-amine
CID 159248313

Frequently Asked Questions

What is the IUPAC name of 6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine?
The IUPAC name of 6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine (CID 159999874) is 6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine.
What is the SMILES notation for 6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine?
The canonical SMILES for 6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine is Cc1cc(C)c2nc(C)n(-c3cncc(Nc4ccc(C(F)(F)F)cc4)n3)c2c1.Cc1nc2cc(F)c(F)cc2n1-c1cncc(Nc2ccc(N3CCOCC3)nc2)n1.Cc1nc2ccccc2n1-c1cncc(NC2Cc3ccccc3C2)n1.Cc1nc2ccccc2n1-c1cncc(Nc2nc3ccccc3s2)n1.FC(F)(F)c1ccc(Nc2cncc(-c3c(C4CC4)nc4ncccn34)n2)cc1.
What is the InChIKey of 6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine?
The InChIKey is OIAJAKVAVIBCJI-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H18F3N5.C21H19F2N7O.C21H19N5.C20H15F3N6.C19H14N6S/c1-12-8-13(2)20-17(9-12)29(14(3)26-20)19-11-25-10-18(28-19)27-16-6-4-15(5-7-16)21(22,23)24;1-13-26-17-8-15(22)16(23)9-18(17)30(13)21-12-24-11-19(28-21)27-14-2-3-20(25-10-14)29-4-6-31-7-5-29;1-14-23-18-8-4-5-9-19(18)26(14)21-13-22-12-20(25-21)24-17-10-15-6-2-3-7-16(15)11-17;21-20(22,23)13-4-6-14(7-5-13)26-16-11-24-10-15(27-16)18-17(12-2-3-12)28-19-25-8-1-9-29(18)19;1-12-21-13-6-2-4-8-15(13)25(12)18-11-20-10-17(23-18)24-19-22-14-7-3-5-9-16(14)26-19/h4-11H,1-3H3,(H,27,28);2-3,8-12H,4-7H2,1H3,(H,27,28);2-9,12-13,17H,10-11H2,1H3,(H,24,25);1,4-12H,2-3H2,(H,26,27);2-11H,1H3,(H,22,23,24).
What are the key properties of 6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine?
6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine has a molecular weight of 1917.05 g/mol, XLogP of 21.89, 17 rotatable bonds, 5 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 6-(2-cyclopropylimidazo[1,2-a]pyrimidin-3-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine;6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-(6-morpholin-4-yl-3-pyridinyl)pyrazin-2-amine;N-(2,3-dihydro-1H-inden-2-yl)-6-(2-methylbenzimidazol-1-yl)pyrazin-2-amine;N-[6-(2-methylbenzimidazol-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-amine;N-[4-(trifluoromethyl)phenyl]-6-(2,4,6-trimethylbenzimidazol-1-yl)pyrazin-2-amine is sourced from PubChem (CID 159999874), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).